Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2910
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
August 19, 2020
0Primary Completion Date
January 10, 2023
0Study Completion Date
February 16, 2023
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Placebo0
LY34718510
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus0
Last Updated
November 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Participant0
Investigator0
Study summary
The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
